Effects of Maternal Mental Health on Engagement in Favorable Health Practices During Pregnancy.

INTRODUCTION: A woman's health practices during pregnancy are associated with maternal and neonatal outcomes. Yet limited research has examined predictors of a woman's engagement in favorable health practices, particularly in pregnant women at greatest risk for adverse outcomes. We examined the role of mental health on engagement in favorable health practices during pregnancy in a sample of pregnant, low-income, predominantly African American women. METHODS: A convenience sample of pregnant women was obtained from 3 obstetric clinics within a large Mid-Atlantic academic health system. Pregnant women (N = 166) completed measures of depression, social support, and engagement in favorable health practices during their second trimester. Six domains of health practices (ie, balance of rest and exercise, safety measures, nutrition, substance use, health care access, access to pregnancy-related information) were assessed by the Health Practices in Pregnancy Questionnaire-II. Multiple linear regression was used to examine predictors of engagement in favorable health practices. RESULTS: Fifty-nine percent of the study participants experienced depressive symptomatology during pregnancy. Multivariate linear regression modeling demonstrated that increased depressive symptoms, decreased social support, young age, and prepregnancy overweight or obesity were significant predictors of nonengagement in favorable health practices during pregnancy. DISCUSSION: Findings suggest that pregnant women with poor mental health (eg, depressive symptomatology, poor social support) and specific sociodemographic characteristics (eg, young age, prepregnancy overweight or obesity) were less likely to engage in favorable health practices during pregnancy. Health care providers are uniquely positioned to assess a woman's mental health and related indicators to optimize pregnancy and neonatal outcomes.

Estrogenic regulation of dopaminergic neurons in the opportunistically breeding zebra finch.

Steroid-induced changes in dopaminergic activity underlie many correlations between gonadal hormones and social behaviors. However, the effects of steroid hormones on the various behaviorally relevant dopamine cell groups remain unclear, and ecologically relevant species differences remain virtually unexplored. We examined the effects of estradiol (E2) manipulations on dopamine (DA) neurons of male and female zebra finches (Taeniopygia guttata), focusing on numbers of tyrosine hydroxylase-immunoreactive (TH-ir) cells in the A8-A15 cell groups, and on TH colocalization with Fos, conducted in the early A.M., in order to quantify basal transcriptional activity. TH is the rate-limiting enzyme for catecholamine synthesis, and specifically DA in the A8-A15 cell groups. In contrast to other examined birds and mammals, reducing E2 levels with the aromatase-inhibitor Letrozole failed to alter TH-ir neuron numbers within the ventral tegmental area (VTA; A10), while increasing neuron numbers in the central gray (CG; A11) and caudal midbrain A8 populations. Consistent with findings in other birds, but not mammals, we also found no effects of E2 manipulations (Letrozole or Letrozole plus E2 replacement) on TH-Fos colocalization in any location. In accordance with previous observations in both mammals and birds, E2 treatment decreased the number of TH-ir neurons in the A12 population of the tuberal hypothalamus, a cell group that inhibits the release of prolactin. In general, males and females exhibited similar TH-ir neuron numbers, although males exhibited significantly more TH-ir neurons in the A11 CG population than did females. These results suggest partial variability in E2 regulation of DA across species.